Livzon Pharmaceutical Group Inc

Research Livzon Pharmaceutical Group Inc (000513.SZ) on Bullrun: market cap CNY 24.82B, P/E 14.8, dividend yield 8.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 24.82B; P/E is 14.8; dividend yield is 8.8%.

Peer valuation comparison

Latest P/E is 14.79x versus a Healthcare sector median of 21.75x (32.0% below).

Latest dividend yield is 8.77% versus a Healthcare sector median of 2.4% (265.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 24.82B14.88.8%2.45

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.45 CNY, yield 8.8%.

About Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Livzon Pharmaceutical Group Inc's market cap?

Livzon Pharmaceutical Group Inc's market capitalization is CNY 24.82B.

What is Livzon Pharmaceutical Group Inc's P/E ratio?

Livzon Pharmaceutical Group Inc's price-to-earnings (P/E) ratio is 14.8.

Does Livzon Pharmaceutical Group Inc pay a dividend?

Livzon Pharmaceutical Group Inc has a dividend yield of 8.8%.

What does Livzon Pharmaceutical Group Inc do?

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally.